Upload Avatar (500 x 500)
Feiyan Liu
Life Science
Zhejiang University
Zhejiang
Language: Chinese, English
Anti-Apoptosis
Drug Resistance
Tumor Cells
Metastasis
Natural Drugs
Traditional Chinese Medicine
Drug Development
Adjuvant Therapy
Pharmacodynamics
Clinical Studies
Areas of Focus
- Molecular mechanisms of tumor cell anti-apoptosis and multi-drug resistance
- Anti-tumor metastasis research
- Development of natural anti-tumor drugs (traditional Chinese medicine), screening of adjuvant drugs for tumors, and preclinical pharmacodynamic studies
Work Experience
- 2000.11-present: Associate Professor at Zhejiang University, School of Life Sciences
- 1989.7-1997.2: Senior Engineer at Hangzhou Garden Research Institute
- 1997.2-1997.12: Senior Engineer at Hangzhou Garden and Cultural Relics Bureau, Science and Technology Department
Academic Background & Achievements
- 2003-2006: PhD in Life Sciences, Zhejiang University
- 1986-1989: Master of Science in Biology, Zhejiang University (formerly Hangzhou University)
- 1982-1986: Bachelor of Science in Biology, Zhejiang University (formerly Hangzhou University)
Publications
- DMFC (3,5-Dimethyl-7H-Furo[3,2-g]Chromen-7-One) regulates Bim to trigger Bax and Bak activation to suppress drug-resistant human hepatoma, Feiyan Liu*, 2017
- Clitocine potentiates TRAIL-mediated apoptosis in human colon cancer cells by promoting Mcl-1 degradation, Feiyan Liu*, 2016
- Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to induce myeloid derived suppressor cell death, Feiyan Liu*, 2016
